Jouke P Bokma1, Koen C de Wilde2, Hubert W Vliegen3, Arie P van Dijk4, Joost P van Melle5, Folkert J Meijboom6, Aeilko H Zwinderman7, Maarten Groenink1, Barbara J M Mulder1, Berto J Bouma1. 1. Department of Cardiology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands2Interuniversity Cardiology Institute of the Netherlands, Utrecht, the Netherlands. 2. Department of Cardiology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands. 3. Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands. 4. Department of Cardiology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands. 5. Department of Cardiology, University of Groningen, Groningen University Medical Center, Groningen, the Netherlands. 6. Department of Cardiology, Utrecht University Medical Center, Utrecht, the Netherlands. 7. Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center Amsterdam, Amsterdam, the Netherlands.
Abstract
Importance: Adults late after total correction of tetralogy of Fallot (TOF) are at risk for major complications. Cardiovascular magnetic resonance (CMR) imaging is recommended to quantify right ventricular (RV) and left ventricular (LV) function. However, a commonly used risk model by Khairy et al requires invasive investigations and lacks CMR imaging to identify high-risk patients. Objective: To implement CMR imaging in noninvasive risk stratification to predict major adverse clinical outcomes. Design, Setting, and Participants: This multicenter study included 575 adult patients with TOF (4.083 patient-years at risk) from a prospective nationwide registry in whom CMR was performed. This study involved 5 tertiary referral centers with a specialized adult congenital heart disease unit. Multivariable Cox hazards regression analysis was performed to determine factors associated with the primary end point. The CMR variables were combined with the noninvasive components of the Khairy et al risk model, and the C statistic of the final noninvasive risk model was determined using bootstrap sampling. The data analysis was conducted from January to December 2016. Main Outcomes and Measures: The composite primary outcome was defined as all-cause mortality or ventricular arrhythmia, defined as aborted cardiac arrest or documented ventricular fibrillation and ventricular tachycardia (lasting ≥30 seconds or recurrent symptomatic). Results: Of the 575 patients with TOF, 57% were male, and the mean (SD) age was 31 (11) years. During a mean (SD) follow-up of 7.1 (3.5) years, the primary composite end point occurred in 35 patients, including all-cause mortality in 13 patients. Mean (SD) RV ejection fraction (EF) was 44% (10%), and mean (SD) LV EF was 53% (8%). There was a correlation between RV EF and LV EF (R, 0.36; 95% CI, 0.29-0.44; P < .001). Optimal thresholds for ventricular function (RV EF <30%: hazard ratio, 3.90; 95% CI, 1.84-8.26; P < .001 and LV EF <45%: hazard ratio, 3.23; 95% CI, 1.57-6.65; P = .001) were independently predictive in multivariable analysis. Both thresholds were included in a point-based noninvasive risk model (C statistic, 0.75; 95% CI, 0.63-0.85) and combined with the noninvasive components of the Khairy et al risk model. Conclusions and Relevance: In patients with repaired TOF, biventricular dysfunction on CMR imaging was associated with major adverse clinical outcomes. The quantified thresholds (RV EF <30% and LV EF <45%) may be implemented in noninvasive risk stratification.
Importance: Adults late after total correction of tetralogy of Fallot (TOF) are at risk for major complications. Cardiovascular magnetic resonance (CMR) imaging is recommended to quantify right ventricular (RV) and left ventricular (LV) function. However, a commonly used risk model by Khairy et al requires invasive investigations and lacks CMR imaging to identify high-risk patients. Objective: To implement CMR imaging in noninvasive risk stratification to predict major adverse clinical outcomes. Design, Setting, and Participants: This multicenter study included 575 adult patients with TOF (4.083 patient-years at risk) from a prospective nationwide registry in whom CMR was performed. This study involved 5 tertiary referral centers with a specialized adult congenital heart disease unit. Multivariable Cox hazards regression analysis was performed to determine factors associated with the primary end point. The CMR variables were combined with the noninvasive components of the Khairy et al risk model, and the C statistic of the final noninvasive risk model was determined using bootstrap sampling. The data analysis was conducted from January to December 2016. Main Outcomes and Measures: The composite primary outcome was defined as all-cause mortality or ventricular arrhythmia, defined as aborted cardiac arrest or documented ventricular fibrillation and ventricular tachycardia (lasting ≥30 seconds or recurrent symptomatic). Results: Of the 575 patients with TOF, 57% were male, and the mean (SD) age was 31 (11) years. During a mean (SD) follow-up of 7.1 (3.5) years, the primary composite end point occurred in 35 patients, including all-cause mortality in 13 patients. Mean (SD) RV ejection fraction (EF) was 44% (10%), and mean (SD) LV EF was 53% (8%). There was a correlation between RV EF and LV EF (R, 0.36; 95% CI, 0.29-0.44; P < .001). Optimal thresholds for ventricular function (RV EF <30%: hazard ratio, 3.90; 95% CI, 1.84-8.26; P < .001 and LV EF <45%: hazard ratio, 3.23; 95% CI, 1.57-6.65; P = .001) were independently predictive in multivariable analysis. Both thresholds were included in a point-based noninvasive risk model (C statistic, 0.75; 95% CI, 0.63-0.85) and combined with the noninvasive components of the Khairy et al risk model. Conclusions and Relevance: In patients with repaired TOF, biventricular dysfunction on CMR imaging was associated with major adverse clinical outcomes. The quantified thresholds (RV EF <30% and LV EF <45%) may be implemented in noninvasive risk stratification.
Authors: Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma Journal: Eur Heart J Date: 2010-08-27 Impact factor: 29.983
Authors: A L Knauth; K Gauvreau; A J Powell; M J Landzberg; E P Walsh; J E Lock; P J del Nido; T Geva Journal: Heart Date: 2006-11-29 Impact factor: 5.994
Authors: Gijsbert F L Kapel; Frédéric Sacher; Olaf M Dekkers; Masaya Watanabe; Nico A Blom; Jean-Benoît Thambo; Nicolas Derval; Martin J Schalij; Zakaria Jalal; Adrianus P Wijnmaalen; Katja Zeppenfeld Journal: Eur Heart J Date: 2017-01-21 Impact factor: 29.983
Authors: Paul Khairy; George F Van Hare; Seshadri Balaji; Charles I Berul; Frank Cecchin; Mitchell I Cohen; Curt J Daniels; Barbara J Deal; Joseph A Dearani; Natasja de Groot; Anne M Dubin; Louise Harris; Jan Janousek; Ronald J Kanter; Peter P Karpawich; James C Perry; Stephen P Seslar; Maully J Shah; Michael J Silka; John K Triedman; Edward P Walsh; Carole A Warnes Journal: Heart Rhythm Date: 2014-05-09 Impact factor: 6.343
Authors: M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington Journal: Lancet Date: 2000-09-16 Impact factor: 79.321
Authors: Jouke P Bokma; Michiel M Winter; Thomas Oosterhof; Hubert W Vliegen; Arie P van Dijk; Mark G Hazekamp; Dave R Koolbergen; Maarten Groenink; Barbara J Mulder; Berto J Bouma Journal: Eur Heart J Date: 2015-10-27 Impact factor: 29.983
Authors: Rachel M Wald; Idith Haber; Ron Wald; Anne Marie Valente; Andrew J Powell; Tal Geva Journal: Circulation Date: 2009-03-02 Impact factor: 29.690
Authors: Anne Marie Valente; Kimberlee Gauvreau; Gabriele Egidy Assenza; Sonya V Babu-Narayan; Jenna Schreier; Michael A Gatzoulis; Maarten Groenink; Ryo Inuzuka; Philip J Kilner; Zeliha Koyak; Michael J Landzberg; Barbara Mulder; Andrew J Powell; Rachel Wald; Tal Geva Journal: Heart Date: 2013-10-31 Impact factor: 5.994
Authors: Francisco J Contijoch; Daniel W Groves; Zhennong Chen; Marcus Y Chen; Elliot R McVeigh Journal: Int J Cardiol Date: 2017-09-29 Impact factor: 4.164
Authors: Pia Sjöberg; Sebastian Bidhult; Jelena Bock; Einar Heiberg; Håkan Arheden; Ronny Gustafsson; Shahab Nozohoor; Marcus Carlsson Journal: Eur Radiol Date: 2018-04-17 Impact factor: 5.315
Authors: Ana Cristina Andrade; Michael Jerosch-Herold; Philip Wegner; Dominik Daniel Gabbert; Inga Voges; Minh Pham; Ravi Shah; Jürgen Hedderich; Hans-Heiner Kramer; Carsten Rickers Journal: J Am Heart Assoc Date: 2019-08-31 Impact factor: 5.501
Authors: Alexander C Egbe; Rahul Vojjini; Patricia A Pellikka; Crystal Bonnichsen; Jason H Anderson; Nathaniel W Taggart Journal: CJC Open Date: 2020-02-24
Authors: Alexander C Egbe; Patricia A Pellikka; Arslan Afzal; Vaibhav Jain; Sahith Thotamgari; William R Miranda; Heidi M Connolly Journal: CJC Open Date: 2019-11-18